H2020 - A Turkish company experienced in additive manufacturing and medical 3D printing based on custom made implant production, is looking for partners for a Eurostars project

Status

4263

Annotation

An innovative Turkish company specialized in additive manufacturing and medical 3D printing focuses on custom made implant production for craniomaxillofacial patients. Using custom made implants creates biodegradable alternatives that can deliver benefits in a more controlled fashion at the defect site. The company is looking for partners to submit a proposal for the Eurostars programme.

Offer description

An innovative Turkish company founded in 2013 and operated in Ankara, focuses on additive manufacturing and 3D printing technologies as a result of its no geometry boundaries philosophy. The company aims to replace metal or polymeric implants with biodegradable alternatives that also have the ability to deliver drugs in a controlled fashion at the defect site. Many patients need craniomaxillofacial implants as a result of work accidents, congenital deficiencies and diseases like cancer. Craniomaxillofacial bone loss cases are primarily operated with custom made implants which are made from metal or plastic material. However, none of the metal or plastic implants can be applied to patients before the age of 20. These patients are currently treated with either using patients own bone or using a highly customized implant made from metals or plastic. However, using patients own bone and using metal or plastic implants has two major downsides. These techniques cannot be applied to children since their pediatric development still continues and treatments with these techniques have the risk of infections. With the biodegradability that company offers, craniomaxillofacial surgery is made possible for children and it improves healing progress with bioactive agents that deliver through controlled release mechanisms. This alternative approach with a scale-up potential became possible with the advancements in 3D printing due to its groundbreaking properties in terms of customization capabilities and ease of logistics with the use of digital 3D models. For their custom made implants, the company is looking for reliable R&D partners such as institutes and universities experienced on custom made implants; additive manufacturing process development; preclinical/clinical trial evaluation of the medical devices; medical device directive (MDD) and/or medical device regulation (MDR); know-how on tissue engineering and/or orthopaedics and also for commercialization stages of a Eurostars project proposal on custom made biodegradable craniomaxillofacial implants. Project duration will be 104 weeks, the deadline for expression of interest is 03/07/2020 and the deadline for the call is 03/09/2020.

Innovations and advantages

- Having a professional team that has experience heavily on medical solutions and custom made implants. - Technology offers shortened surgery duration by 70% and also decreases treatment costs by 30%. - The biodegradable implant makes surgery possible for young pediatric patients and improves healing duration by delivering proper medicine. - Opportunities to recover any bone loss with an implant that will turn into patients own bone tissue is the main innovation that the company offers. This innovation will also prevent infection risks and accelerate the recovery periods.

Technology keywords

06001013 Medical Technology / Biomedical Engineering
06001017 Surgery
06001020 Physiotherapy, Orthopaedic Technology

Market application codes

05003003 Surgical implants
05005015 Orthopaedics

Intellectual property rights

Patents granted

Profile date

30.12.2021